The facility has secured an updated EU-GMP license from the Saxony-Anhalt State Office for Social Affairs, Youth and Health, clearing the way for full-scale operations. By integrating proprietary genetics from its Canadian R&D facility and applying standardized cultivation methodologies, Aurora aims to align the German site with the high-performance metrics of its global network.

Alex Miller, executive vice president of operations and supply chain, noted that the transformation marks a strategic milestone for the company’s presence in Germany. As one of only three domestic producers currently operating in the country, Aurora intends for the site to bolster supply chain resilience while supporting local job creation in the region.